The aim of the study is to obtain knowledge of the impact of basal stimulation therapy on the health status of adults suffering from schizophrenia and requiring permanent institutional care.
The use of basal stimulation therapy in many European centres for several decades, combined with the limited amount of scientific evidence, justifies undertaking the proposed research. Available evidence indicates reduced anxiety and improved quality of life. No such studies have previously been conducted in institutionalized patients with schizophrenia.
women and men aged ≥ 55 years,
consent of the legal guardian/caregiver to participate in the study,
schizophrenia clinically confirmed for at least 5 years, with predominance of negative symptoms,
stable drug therapy (treatment unchanged for at least 3 months)
lack of consent to participate in the study;
pregnancy
general contraindications (acute inflammatory conditions and diseases accompanied by fever, venous thrombosis, unstable arterial hypertension , early condition after contrast-enhanced computed tomography, early condition after lumbar puncture, general serious condition of the patient )
exacerbation of the main disease (acute psychosis, severe anxiety, tendency to active aggression, visual seizures)
The Jerzy Kukuczka Academy of Physical Education in Katowice
Lead sponsor
Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland
Collaborator